Bovine colostrum: what it is, and what it has actually been tested for

Bovine colostrum went from a niche sports-nutrition powder to a mainstream wellness product in about three years, and the marketing arrived long before the reading did. The pitch is intuitive and emotionally effective: this is the first milk, nature’s starter kit, packed with antibodies and growth factors. All of that is literally true. The problem is what happens next in the argument. Colostrum is not a molecule. It is a mixture — dozens of active components at wildly different concentrations, made for a newborn calf with an open gut, then heated, dried and put in a tub. That makes “does colostrum work?” a badly posed question, and it makes the real questions harder: which component, surviving what, doing what, in whom, at what dose, and at what price per gram. There are honest answers to some of those. There are none at all to others.

What bovine colostrum actually is

Colostrum is the secretion a mammary gland produces in the first hours after birth, before it switches over to mature milk. Its composition is dictated by a piece of anatomy: how a species’ placenta transfers immunity before birth determines what has to be delivered after it. In ungulates — cattle included — the placenta transfers essentially no immunoglobulin in utero, so the entire job of passive immunity falls on colostrum, and bovine colostrum is correspondingly dominated by IgG. Humans transfer IgG across the placenta before birth, so human colostrum is comparatively richer in secretory IgA, whose job is local defence at the mucosa rather than systemic immunity.^[1] That is the first thing worth internalising: bovine colostrum is built for a problem human newborns do not have.

Alongside the immunoglobulins sit lactoferrin, lysozyme, leukocytes, a set of growth factors (IGF-1, TGF-β, epidermal growth factor), oligosaccharides, hormones and a long tail of minor bioactives — components whose documented role is supporting development of the gastrointestinal tract and the local immune system in a newborn.^[1][2] The oligosaccharide and antimicrobial-peptide fractions are real and interesting. They are also, in a commercial powder, unquantified.

The lactoferrin in that list is the same protein sold on its own, purified from whey, with its own trial base — and that comparison is instructive enough that we gave it a separate page. Read lactoferrin: what the evidence actually shows if you are weighing the two, because the single most useful lesson from that literature transfers directly here: the larger and better-controlled the trial got, the smaller the effect became. Colostrum has not yet had its ELFIN — the 2,200-infant trial that flattened a decade of promising small lactoferrin studies. Keep that in mind while reading everything below.

One more framing point, because it explains the supply chain. The reason colostrum exists commercially at all is that dairy cattle produce far more of it than a calf drinks, and the veterinary standard for what a calf actually needs is well defined: US consensus recommendations grade passive transfer by serum IgG, with ≥25.0 g/L rated excellent and <10 g/L rated poor, and roughly 90% of sampled US dairy calves already clear the older 10 g/L bar.^[3] A well-run operation can meet the calf’s requirement and still have surplus. A badly run one cannot. That is not a sentimental aside — it is the sourcing question, and we come back to it under buying.

The digestion problem, stated honestly

Here is the objection every skeptical reader raises, correctly: IgG is a protein, you are swallowing it, and stomach acid and pepsin exist. The usual reply from sellers — “colostrum is absorbed intact” — is wrong. The usual reply from critics — “you just digest it into amino acids” — is also wrong. The measured answer sits in between, and it reframes what colostrum could plausibly do.

The cleanest human experiment is thirty years old and still the one to cite. Six volunteers with an end ileostomy — meaning everything leaving the small intestine could be collected and assayed — took 5 g of a hyperimmune bovine immunoglobulin concentrate containing 2.1 g of bovine IgG. A mean of 1,033 mg of bovine IgG was recovered in the ileal fluid: 49% of the ingested dose. Crucially, it was not just protein mass — specific anti-toxin IgG was detectable in the ileal fluid and toxin-neutralising activity was retained, correlating tightly with IgG concentration (r = 0.95).^[4] Adding antacid or omeprazole did not significantly increase recovery. Enteric coating made things worse: the capsules frequently passed intact or barely opened, and free IgG in the effluent collapsed to 89 mg.^[4]

Two conclusions follow, and they cut in opposite directions for the marketing.

• About half of it survives, functionally. That is a great deal more than most people assume, and it is the strongest single fact in colostrum’s favour. It also came from a high-dose, hyperimmune concentrate in people missing a colon, which is a generous test case rather than a typical one.^[4]
• Surviving to the ileum is not the same as being absorbed into blood. Nothing in that experiment shows intact bovine IgG entering the circulation of an adult, and nothing needs to. Neutralising a toxin in the gut lumen is a local action. This is the honest mechanistic frame for colostrum: a gut-luminal agent, not a systemic one. Which is exactly why the human evidence clusters where it does — gut barrier and gut infection — and thins to nothing for skin, hair and body composition.

Adult gut “closure” is the reason. A newborn calf absorbs intact immunoglobulin across the intestinal epithelium for a matter of hours; that window shuts. Bovine colostrum products are supplements added to normal nutrition rather than passive-immunity vehicles for adults, and reviewers of the paediatric literature are explicit that colostrum is nutritionally imbalanced relative to human milk and should not be fed exclusively even to infants.^[2] If it were freely absorbed into adult blood, that would be a safety problem, not a feature.

Where the evidence is genuinely best: a gut under stress

Intense exercise, heat and NSAIDs all transiently increase intestinal permeability. That is a measurable phenomenon with a standard assay — you swallow two sugars of different molecular size and measure the ratio in urine — and it is the endpoint on which colostrum has been tested most.

The pooled result is positive. A 2024 systematic review and meta-analysis of ten randomised trials found bovine colostrum significantly reduced the 5-hour urinary lactulose/rhamnose ratio (mean difference −0.24, 95% CI −0.43 to −0.04) and the lactulose/mannitol ratio (−0.01, 95% CI −0.02 to −0.001).^[8] Read the heterogeneity before you read the conclusion: I² = 99% for the primary outcome — about as much between-study disagreement as it is possible to have — and the reviewers found no effect at all on plasma I-FABP, a marker of actual enterocyte damage (MD 2.30, 95% CI −293.9 to 298.5).^[8] So: the sugar-ratio endpoint moved; the cell-damage endpoint did not. The authors’ own conclusion asks for more trials at defined quality, dose and duration.

Underneath the pooled figure, the individual trials are worth seeing, because they disagree spectacularly.

• The clean positive. Sixteen athletes at peak training, 20 days, 500 mg of colostrum twice daily versus whey placebo, double-blind. Lactulose/mannitol ratios normalised in the colostrum group and the change was significantly better than placebo, with stool zonulin moving in the same direction (smaller effect, still significant on the delta comparison).^[9] Small, but the right design.
• The NSAID trial that started it all. Seven healthy men in a randomised crossover took indomethacin 50 mg three times daily for five days. In the control arm permeability tripled (lactulose/rhamnose 0.36 → 1.17, P < 0.01); with colostrum co-administered there was no significant rise. In a second arm of patients already on long-term NSAIDs, baseline permeability was low and colostrum did nothing.^[12] That second half matters: it suggests colostrum blunts an acute insult rather than repairing a chronic state.
• The trial that went the wrong way. Thirty men ran three times a week for eight weeks on 60 g/day of colostrum, whey or control. The lactulose/rhamnose ratio increased significantly more on colostrum (+251%) than on whey (+21%) or control (−7%).^[10] The authors’ proposed explanation is genuinely interesting rather than dismissive: colostrum may increase macromolecular transport across the gut, as it is designed to do in a neonate. This trial is in the meta-analysis. It is a large part of why I² is 99%.
• The well-powered null. A double-blind randomised crossover gave 1.7 g/kg/day — roughly 120 g/day for a 70 kg man, far above any consumer dose — for seven days before 90 minutes of exercise at 30 °C. Permeability, I-FABP, cytokines, physiological strain and performance were all unaffected by colostrum, in trained and untrained men alike.^[11] Enormous dose, hostile conditions, nothing.

A broader systematic review of supplements for exercise-associated gut damage places colostrum among the better-supported options alongside glutamine, while flagging large heterogeneity across the literature.^[21] That is a fair summary: colostrum is one of the few things with any randomised evidence at the exercise-stressed gut barrier, and the evidence is inconsistent. For the pharmaceutical end of the same question — a molecule designed specifically to close tight junctions, and what happened when it was tested properly — see larazotide.

Respiratory infections in athletes: the other real signal

The second defensible claim is narrower than the marketing but better tested than most. A 2016 systematic review and meta-analysis searched ten databases including trial registries and found five randomised trials, 152 participants, all in adults engaged in regular exercise training. Over 8–12 weeks, colostrum reduced the incidence rate of upper respiratory symptom days by 44% (rate ratio 0.56, 95% CI 0.43–0.72, P < 0.001) and symptom episodes by 38% (0.62, 95% CI 0.40–0.99, P = 0.04).^[13]

The reviewers are unusually candid about what that is worth. Four of the five trials were rated at moderate or high risk of overall bias, largely because of incomplete method reporting; individual study estimates were imprecise; and the review closes by calling for “an appropriately designed and adequately powered randomised control trial” that has still not been run.^[13] One point in the finding’s favour, which the authors make and which is easy to miss: most of the included studies did not individually report significant effects, which argues against publication bias driving the pooled result.^[13]

And then the mechanism fails to show up. A separate meta-analysis of ten RCTs in 239 trained and physically active people found colostrum had no or fairly low impact on serum IgA and IgG, lymphocytes, neutrophils, or salivary IgA — the reviewers noting explicitly that previous work has shown reduced respiratory infections while “there is a gap of scientific knowledge on the mechanisms underlying these effects.”^[14] A narrative review of the whole sport-and-exercise literature reaches the same shape of conclusion: the balance of evidence for gut permeability and illness risk is positive, particularly during intensified training, while the mechanism remains open and product-to-product bioactivity varies enough that dose-response findings apply only to the specific product tested.^[15]

Note the population every time. These are people training hard enough to be immunosuppressed by it. There is no equivalent trial base for a desk worker taking a scoop in their coffee, and a 44% reduction in symptom days among overreaching athletes is not a number you get to carry across.

Claim versus test

The IGF-1 question, answered from both sides

Colostrum contains IGF-1. This generates two opposite claims, and both are wrong.

The promise: that oral colostrum raises systemic IGF-1 and therefore builds muscle or slows ageing. The fear: that raising IGF-1 could stimulate tissues expressing IGF-1 receptors. Both require the same premise — that ingested IGF-1 reaches the circulation and moves the needle — and that premise has been tested directly three times.

A 2020 paper reported all three protocols in one place: 16 healthy men given 40 g of colostrum or placebo with moderate exercise over 4.5 hours; a double-blind parallel-group RCT at 20 g/day for four weeks; and a second at 20 g/day for twelve weeks in 54 people. Plasma IGF-1 did not change in any of them (all treatment-group and interaction P values non-significant, from a baseline of 130 ± 36 ng/mL).^[16] Eighteen years earlier, nine endurance-trained men took a far larger 60 g/day for four weeks: serum IGF-1 was 31 ± 13 nM/L before and 33 ± 9 nM/L after, IGFBP-3 unchanged, with no acute effect two hours after the final dose.^[17] A resistance-training trial in older adults at 60 g/day for eight weeks likewise found no change in plasma IGF-1.^[19] The narrative review of the field concludes the same thing: early suggestions that colostrum raises systemic IGF-1 are not supported by the balance of evidence across doses and durations.^[15]

This is a rare case where the null result is good news twice over. The muscle-and-longevity IGF-1 pitch is unsupported, and so is the cancer-risk worry that circulates alongside it. For what an IGF-1 analogue actually does when it is delivered systemically — and why that is a different and far more serious conversation — see IGF-1 LR3.

Where the marketing outruns the evidence

“Gut healing” and leaky gut in healthy people. This is the biggest claim and the emptiest. Every permeability trial above first provoked the gut — eight weeks of running, 90 minutes at 30 °C, five days of indomethacin, peak competitive training. Searched from the opposite direction, there is no randomised trial enrolling healthy, symptom-free adults with normal baseline permeability and demonstrating an improvement, and the one arm that comes closest is instructive: in patients already on long-term NSAIDs whose baseline permeability had normalised, colostrum did nothing at all.^[12] A systematic review across sick and healthy people reaches the same shape — interesting effects on permeability and on respiratory illness in sportsmen, conflicting results in paediatric populations, and very little evidence in older adults — with studies “highly heterogeneous as regards to population, intervention, outcome and risk of bias.”^[22]

Skin and hair. There is no human trial. The study most often gestured at is a laboratory paper on colostrum-derived exosomes applied to cultured human dermal papilla cells and to mouse dorsal skin, where they promoted proliferation and hair regrowth comparable to minoxidil.^[23] That is real work and it does not support the claim: it is an isolated exosome fraction, applied topically to a mouse, not a scoop of powder in a human. Nothing in the human literature connects oral colostrum to skin or hair outcomes.

Body composition. The evidence is two isolated endpoints, never replicated. In 2001, 8 weeks of 20 g/day during combined aerobic and resistance training produced a 1.49 kg increase in bone-free lean body mass versus whey — with no change in any other measure: not treadmill time to exhaustion, not bench press 1RM, not repetitions to failure.^[18] In 2014, 40 older adults on 60 g/day during 8 weeks of resistance training gained more leg press strength than the whey group and had lower bone resorption — but bench press, muscle thickness, lean tissue mass, bone mineral content and cognitive scores improved equally in both arms.^[19] Both trials used whey as the comparator, which is the honest choice and also the reason the effects are small. If you want muscle, the answer is adequate protein and creatine, both of which are cheaper and far better evidenced.

Where it does look useful outside sport. Worth stating for balance: in a randomised controlled trial in 87 adults with HIV-associated diarrhoea in Northern Uganda, adding 50 g of a colostrum-based supplement twice daily to standard anti-diarrhoeal treatment reduced mean daily stool frequency by 79% versus 58% in controls, with gains in body weight and CD4+ count.^[20] That is a single-blind trial of a specific commercial product in a severely affected population — not transferable to a healthy adult’s digestion, but a reminder that the gut-luminal mechanism has real clinical traction where there is real pathology to act on.

Buying it: the product variables that actually decide value

This is where colostrum differs most from a single-molecule supplement, and where almost all of the consumer money is currently being wasted. Six things matter, roughly in order.

1. IgG percentage, disclosed as a number. Colostrum-derived powders are traded between manufacturers on the basis of IgG content — it is the industry’s own quality marker, with validated AOAC collaborative-study methods (protein-G affinity chromatography and surface plasmon resonance) for measuring it in exactly this matrix: colostrum powders, tablets and dietary supplements.^[7] The test exists, it is standardised, and your supplier already knows the number. If a brand will not print it, that is a choice, not a limitation. Brands that do disclose typically state something in the 15–30% range by weight; a blend padded with whey or skimmed-milk powder can be far lower and will still legally say “colostrum” on the front.

2. First-milking, and how quickly after calving. This is not marketing garnish — it has been measured against a clinical endpoint. A randomised, double-blind, placebo-controlled trial in 31 healthy athletes compared colostrum harvested at 2, 24 and 72 hours after delivery. Only the 2-hour and 24-hour colostrum significantly reduced intestinal permeability; the 72-hour material did not, and the 2-hour material was significantly better than both placebo and the 72-hour group.^[6] Bioactivity falls measurably over the first three days of lactation. “First milking” is a real spec. “Colostrum” with no timing claim may be transition milk.

3. Heat treatment — and the numbers are known. The same lability logic that governs lactoferrin governs colostrum, and someone has quantified it. Relative to unpasteurised liquid colostrum, low-temperature long-time pasteurisation (63 °C, 30 min) denatured about 15% of IgG; high-temperature short-time (72 °C, 15 s) denatured 34%. HTST also cut lactoperoxidase by 81%; LTLT cut lactoferrin by 21%. Gamma-irradiation, used to control microbial load, pushed IgG denaturation to 30–38% on its own and to 60% when stacked on HTST. Anti-inflammatory serpin anti-proteinases were highly sensitive to HTST and irradiation but preserved by LTLT. The authors’ conclusion is a purchasing spec: LTLT followed by spray-drying is the optimal processing route for preserving bioactive proteins.^[5] Reviewers of the paediatric literature make the same point — the bioactives likely work in synergy, so preserving them with gentle processing is critical.^[2] Note the counter-intuitive part: spray-drying is not the villain; the pasteurisation temperature and any irradiation step are.

4. Sourcing, and whether the calves were fed first. There is no certification for this and no way to verify it from a label, which is precisely why it deserves a direct question to the brand. The veterinary benchmark is public: the US consensus standard grades a calf’s passive transfer as excellent at ≥25 g/L serum IgG, and only about a third of 2014-sampled heifer calves met it — meaning a genuine surplus exists on well-managed farms and does not on others.^[3] Ask whether colostrum is collected only after the calf’s full feeding, and whether the farm monitors calf serum IgG. A supplier that has thought about it will have an answer.

5. Dose, and the gap nobody mentions. This is the most important number on this page. The human trials that generated colostrum’s reputation used 20 to 60 g per day— 20 g/day for lean mass,^[18] 60 g/day in the running study,^[10] 60 g/day in the older-adult trial,^[19] 60 g/day in the IGF-1 study,^[17] 100 g/day in the HIV diarrhoea trial,^[20] and roughly 120 g/day in the heat-stress crossover.^[11] Fashionable stick-pack and capsule products commonly deliver 1–3 g/day. That is between a twentieth and a sixtieth of most trial doses. The honest counterweight is that two of the cleaner permeability trials used only 500 mg twice daily and still hit their endpoint,^[9][6] so low doses are not automatically inert — but those are two small Polish trials of one specific endpoint, and they are the exception. If you are buying on the strength of the respiratory or lean-mass findings, you should be dosing in tens of grams, not in sticks.

6. Price, in dollars per gram of actual IgG. Do this arithmetic once and the category reorganises itself. Bulk spray-dried colostrum powder sells for roughly $0.06–0.12 per gram of powder; boutique flavoured stick packs run roughly $2–4 per gram. That is a 20- to 60-fold spread on the same raw material. Now convert to IgG: at a disclosed 20% IgG, bulk powder is about $0.30–0.60 per gram of IgG; a stick pack at the same 20% is $10–20 per gram of IgG — and if the IgG figure is undisclosed, you cannot compute it at all, which is the point. A month at the 20 g/day trial dose costs roughly $40–70 in bulk powder and is simply not purchasable in stick form at any sane price. The premium is buying flavour, sachets and marketing, not more of the active fraction.

The hard stop. Colostrum is a dairy product. Cow’s-milk protein allergy is an absolute contraindication — the immunoglobulins and caseins are exactly the proteins involved. Lactose intolerance is a different and softer problem: colostrum contains less lactose than mature milk, but it is not lactose-free, and at 20–60 g/day the residual load is not trivial. Reviewers of paediatric use conclude that allergy and intolerance appear unlikely when colostrum is given as a supplement within normal nutrition guidelines,^[2] which is reassurance about typical supplemental amounts, not about trial-sized doses in a sensitive gut. If you react to dairy, this is not the category for you.

Safety

Colostrum is food, and the trials reflect that. The 20-day athlete study reported supplementation was safe and effective on its endpoint;^[9] the 8-week older-adult trial at 60 g/day reported no adverse changes in CRP or IGF-1;^[19] the 12-week IGF-1 protocols were uneventful.^[16] The realistic issues are these:

• Dairy allergy: avoid entirely. Not a tolerance question — an allergy one.^[2]
• GI effects at trial doses. Twenty to sixty grams a day of a milk-solids powder is a meaningful lactose and protein load. Bloating and loose stools are the common complaint, and they are dose-related.
• Microbial control is a real manufacturing concern. Raw colostrum from a barn is not a sterile input, which is why the processing literature discusses gamma-irradiation at all — and why the trade-off between microbial safety and preserved bioactivity is unavoidable rather than optional.^[5] A product with no stated pasteurisation method has not escaped that trade-off; it has just not told you which side it landed on.
• The one thing that is genuinely unknown is long-term daily use in healthy adults. The longest randomised exposures here are 8–12 weeks.^[16][19] Colostrum is being marketed as a permanent daily habit on the strength of three-month trials.

The honest bottom line

Bovine colostrum is not a scam and it is not a breakthrough. It is a real biological material with a narrow, mostly local mechanism — about half of the IgG you swallow reaches the small intestine with its binding and neutralising activity intact,^[4] and that is enough to plausibly do something at the gut barrier and nothing at all for your skin.

The evidence is best exactly where the mechanism predicts and worst exactly where the marketing shouts. Ten randomised trials pool to a real reduction in stress-induced intestinal permeability, at I² = 99% and with one good trial pointing the other way.^[8][10] Five small trials in hard-training adults show 44% fewer respiratory symptom days, four of them at moderate-to-high risk of bias, with no immune-marker change to explain it.^[13][14] Everything else — leaky gut in healthy people, skin, hair, body composition, IGF-1 — is either untested or tested and null.^[16][18][23]

So the reasonable buyer is specific: someone training hard enough that gut symptoms or recurrent upper-respiratory infections are actually costing them training days, buying a first-milking, LTLT-pasteurised, non-irradiated powder with a disclosed IgG percentage, at 20–60 g/day, in bulk, for about the price of a protein powder. Everyone else is paying $2–4 a gram for a flavoured milk-solids sachet at a twentieth of the studied dose, on the strength of claims that were never tested in anyone resembling them. That gap — between a defensible product and the one most people are buying — is the whole story of this category right now.

This article is research information, not medical advice. Bovine colostrum is sold as a dietary supplement and has no FDA approval for any indication — it is not approved to treat or prevent intestinal permeability, “leaky gut,” respiratory infection, diarrhoea or any other condition, and it is not a treatment for an immune disorder. It is a dairy product: anyone with cow’s-milk protein allergy must avoid it entirely, and it is not lactose-free. Persistent digestive symptoms need a diagnosis, not a supplement — do not self-treat suspected coeliac disease, inflammatory bowel disease or chronic infection with colostrum. If you are immunosuppressed, pregnant, giving it to a child, or competing in a drug-tested sport, talk to a licensed clinician or your anti-doping authority before starting it.